Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by MYLAN INSTITUTIONAL
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
016763
SULFAMYLON
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(P) Priority review drug
(V) Orphan drug
017788
RIMSO-50
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
019677
ENLON-PLUS
New Drug Application
Approval
New combination
(S) Standard review drug
019678
ENLON-PLUS
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019832
SULFAMYLON
New Drug Application
Approval
New formulation
(S) Standard review drug
(V) Orphan drug
020298
ALOPRIM
New Drug Application
Approval
New formulation
(P) Priority review drug
(V) Orphan drug
020615
DURACLON
New Drug Application
Approval
New formulation
(S) Standard review drug
(V) Orphan drug
020630
ULTIVA
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021624
DOLOPHINE HYDROCHLORIDE
New Drug Application
Approval
040451
CYANOCOBALAMIN
Abbreviated New Drug Application
Approval
040471
PROMETHAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
040498
DIPHENHYDRAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
040541
SOTRADECOL
Abbreviated New Drug Application
Approval
040647
TESTOSTERONE ENANTHATE
Abbreviated New Drug Application
Approval
040652
TESTOSTERONE CYPIONATE
Abbreviated New Drug Application
Approval
050517
MEFOXIN
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
062757
MEFOXIN
Abbreviated New Drug Application
Approval
063182
MEFOXIN IN PLASTIC CONTAINER
Abbreviated New Drug Application
Approval
065371
EPIRUBICIN HYDROCHLORIDE
Abbreviated New Drug Application
Approval
076092
KETAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
076185
DIMETHYL SULFOXIDE
Abbreviated New Drug Application
Approval
076217
AMIODARONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
076428
MILRINONE LACTATE
Abbreviated New Drug Application
Approval
076474
ESMOLOL HYDROCHLORIDE
Abbreviated New Drug Application
Approval
076488
MESNA
Abbreviated New Drug Application
Approval
077998
CARBOPLATIN
Abbreviated New Drug Application
Approval
078639
FOMEPIZOLE
Abbreviated New Drug Application
Approval
078980
MITOXANTRONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
079033
FOMEPIZOLE
Abbreviated New Drug Application
Approval
079198
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
Abbreviated New Drug Application
Approval
079199
ROCURONIUM BROMIDE
Abbreviated New Drug Application
Approval
088873
ENLON
Abbreviated New Drug Application
Approval
090270
MELPHALAN HYDROCHLORIDE
Abbreviated New Drug Application
Approval
090299
MELPHALAN HYDROCHLORIDE
Abbreviated New Drug Application
Approval
090394
SCANLUX-300
SCANLUX-370
Abbreviated New Drug Application
Approval
090574
COSYNTROPIN
Abbreviated New Drug Application
Approval
090643
IBUTILIDE FUMARATE
Abbreviated New Drug Application
Approval
090664
NICARDIPINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
090874
ISOSULFAN BLUE
Abbreviated New Drug Application
Approval
090924
IBUTILIDE FUMARATE
Abbreviated New Drug Application
Approval
091623
THIAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
091657
TRANEXAMIC ACID
Abbreviated New Drug Application
Approval
200752
DEXRAZOXANE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
201276
CIDOFOVIR
Abbreviated New Drug Application
Approval
202493
CHLOROTHIAZIDE SODIUM
Abbreviated New Drug Application
Approval
202626
ARGATROBAN
Abbreviated New Drug Application
Approval
202881
DEXMEDETOMIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
203554
PENTOSTATIN
Abbreviated New Drug Application
Approval
203624
ACETYLCYSTEINE
Abbreviated New Drug Application
Approval
204404
METHOCARBAMOL
Abbreviated New Drug Application
Approval
204634
ETHACRYNATE SODIUM
Abbreviated New Drug Application
Approval
204680
HYDRALAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
204879
PYRIDOXINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
204949
AZACITIDINE
Abbreviated New Drug Application
Approval
204997
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
205014
NALOXONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
205239
DANTROLENE SODIUM
Abbreviated New Drug Application
Approval
206404
PENTOBARBITAL SODIUM
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval